journal
https://read.qxmd.com/read/38627504/neural-effects-of-psychedelics-complexity-the-key-word
#1
JOURNAL ARTICLE
Brett D M Jones, M Ishrat Husain
No abstract text is available yet for this article.
April 16, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38615126/in-vivo-translocator-protein-in-females-with-autism-spectrum-disorder-a-pilot-study
#2
JOURNAL ARTICLE
Chieh-En Jane Tseng, Camila Canales, Rachel E Marcus, Anjali J Parmar, Baileigh G Hightower, Jennifer E Mullett, Meena M Makary, Alison U Tassone, Hannah K Saro, Paige Hickey Townsend, Kirstin Birtwell, Lisa Nowinski, Robyn P Thom, Michelle L Palumbo, Christopher Keary, Ciprian Catana, Christopher J McDougle, Jacob M Hooker, Nicole R Zürcher
Sex-based differences in the prevalence of autism spectrum disorder (ASD) are well-documented, with a male-to-female ratio of approximately 4:1. The clinical presentation of the core symptoms of ASD can also vary between sexes. Previously, positron emission tomography (PET) studies have identified alterations in the in vivo levels of translocator protein (TSPO)-a mitochondrial protein-in primarily or only male adults with ASD, with our group reporting lower TSPO relative to whole brain mean in males with ASD...
April 13, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38609530/rebound-activation-of-5-ht-neurons-following-ssri-discontinuation
#3
JOURNAL ARTICLE
Helen M Collins, L Sophie Gullino, Dersu Ozdemir, Caroline Lazarenco, Yulia Sudarikova, Elizabeth Daly, Fuencisla Pilar Cuéllar, Raquel Pinacho, David M Bannerman, Trevor Sharp
Cessation of therapy with a selective serotonin (5-HT) reuptake inhibitor (SSRI) is often associated with an early onset and disabling discontinuation syndrome, the mechanism of which is surprisingly little investigated. Here we determined the effect on 5-HT neurochemistry of discontinuation from the SSRI paroxetine. Paroxetine was administered repeatedly to mice (once daily, 12 days versus saline controls) and then either continued or discontinued for up to 5 days. Whereas brain tissue levels of 5-HT and/or its metabolite 5-HIAA tended to decrease during continuous paroxetine, levels increased above controls after discontinuation, notably in hippocampus...
April 12, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38605185/beyond-traditional-pharmacology-evaluating-phosphodiesterase-inhibitors-in-autism-spectrum-disorder
#4
JOURNAL ARTICLE
Fernando E Padovan-Neto, Ana Júlia de Oliveira Cerveira, Aline da Silva, Danilo Leandro Ribeiro
No abstract text is available yet for this article.
April 11, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38600154/am6527-a-neutral-cb1-receptor-antagonist-suppresses-opioid-taking-and-seeking-as-well-as-cocaine-seeking-in-rodents-without-aversive-effects
#5
JOURNAL ARTICLE
Omar Soler-Cedeño, Hannah Alton, Guo-Hua Bi, Emily Linz, Lipin Ji, Alexandros Makriyannis, Zheng-Xiong Xi
Preclinical research has demonstrated the efficacy of CB1 receptor (CB1R) antagonists in reducing drug-taking behavior. However, clinical trials with rimonabant, a CB1R antagonist with inverse agonist profile, failed due to severe adverse effects, such as depression and suicidality. As a result, efforts have shifted towards developing novel neutral CB1R antagonists without an inverse agonist profile for treating substance use disorders. Here, we assessed AM6527, a CB1R neutral antagonist, in addiction animal models...
April 10, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38582939/the-selective-d-3-receptor-antagonist-vk4-116-reverses-loss-of-insight-caused-by-self-administration-of-cocaine-in-rats
#6
JOURNAL ARTICLE
Marios C Panayi, Shohan Shetty, Micaela Porod, Lisette Bahena, Zheng-Xiong Xi, Amy Hauck Newman, Geoffrey Schoenbaum
Chronic psychostimulant use causes long-lasting changes to neural and cognitive function that persist after long periods of abstinence. As cocaine users transition from drug use to abstinence, a parallel transition from hyperactivity to hypoactivity has been found in orbitofrontal-striatal glucose metabolism and striatal D2 /D3 -receptor activity. Targeting these changes pharmacologically, using highly selective dopamine D3 -receptor (D3 R) antagonists and partial agonists, has shown promise in reducing drug-taking, and attenuating relapse in animal models of cocaine and opioid use disorder...
April 6, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38580806/author-correction-sex-differences-in-offspring-risk-and-resilience-following-11%C3%AE-hydroxylase-antagonism-in-a-rodent-model-of-maternal-immune-activation
#7
Julia Martz, Micah A Shelton, Laurel Geist, Marianne L Seney, Amanda C Kentner
No abstract text is available yet for this article.
April 5, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38570645/the-rostromedial-tegmental-nucleus-gates-fat-overconsumption-through-ventral-tegmental-area-output-in-male-rats
#8
JOURNAL ARTICLE
Florian Schoukroun, Katia Befort, Romain Bourdy
Excessive consumption of palatable foods that are rich in fats and sugars has contributed to the increasing prevalence of obesity worldwide. Similar to addictive drugs, such foods activate the brain's reward circuit, involving mesolimbic dopaminergic projections from the ventral tegmental area (VTA) to the nucleus accumbens (NAc) and the prefrontal cortex. Neuroadaptations occurring in this circuit are hypothesized to contribute to uncontrolled consumption of such foods, a common feature of most of eating disorders and obesity...
April 3, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38548878/retraction-note-association-between-neuromelanin-sensitive-mri-signal-and-psychomotor-slowing-in-late-life-depression
#9
Kenneth Wengler, Brandon K Ashinoff, Elena Pueraro, Clifford M Cassidy, Guillermo Horga, Bret R Rutherford
No abstract text is available yet for this article.
March 28, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38548877/altered-excitatory-and-inhibitory-ionotropic-receptor-subunit-expression-in-the-cortical-visuospatial-working-memory-network-in-schizophrenia
#10
JOURNAL ARTICLE
Kirsten E Schoonover, Samuel J Dienel, H Holly Bazmi, John F Enwright, David A Lewis
Dysfunction of the cortical dorsal visual stream and visuospatial working memory (vsWM) network in individuals with schizophrenia (SZ) likely reflects alterations in both excitatory and inhibitory neurotransmission within nodes responsible for information transfer across the network, including primary visual (V1), visual association (V2), posterior parietal (PPC), and dorsolateral prefrontal (DLPFC) cortices. However, the expression patterns of ionotropic glutamatergic and GABAergic receptor subunits across these regions, and alterations of these patterns in SZ, have not been investigated...
March 28, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38528134/kappa-opioid-receptor-stimulation-in-the-nucleus-accumbens-shell-and-ethanol-drinking-differential-effects-by-rostro-caudal-location-and-level-of-drinking
#11
JOURNAL ARTICLE
Breanne E Pirino, Annie Hawks, Brody A Carpenter, Pelagia G Candelas, Andrew T Gargiulo, Genevieve R Curtis, Anushree N Karkhanis, Jessica R Barson
Although the kappa-opioid receptor (KOR) and its endogenous ligand, dynorphin, are believed to be involved in ethanol drinking, evidence on the direction of their effects has been mixed. The nucleus accumbens (NAc) shell densely expresses KORs, but previous studies have not found KOR activation to influence ethanol drinking. Using microinjections into the NAc shell of male and female Long-Evans rats that drank under the intermittent-access procedure, we found that the KOR agonist, U50,488, had no effect on ethanol drinking when injected into the middle NAc shell, but that it promoted intake in males and high-drinking females in the caudal NAc shell and high-drinking females in the rostral shell, and decreased intake in males and low-drinking females in the rostral shell...
March 25, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38528133/does-acute-cannabidiol-cbd-use-impair-performance-a-meta-analysis-and-comparison-with-placebo-and-delta-9-tetrahydrocannabinol-thc
#12
JOURNAL ARTICLE
Lindsay A Lo, April L Christiansen, Justin C Strickland, Carly A Pistawka, Lauren Eadie, Ryan Vandrey, Caroline A MacCallum
Cannabidiol (CBD) is widely used and believed to be non-intoxicating, lacking acute performance effects (e.g., non-impairing). However, a synthesis of data has not evaluated this. This meta-analysis synthesized data from controlled human laboratory studies that evaluated if acute CBD use impairs performance. Performance on objective and subjective measures of cognitive and psychomotor function were used as markers for potential performance changes and impairment. Studies were identified through systematic database searches...
March 25, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38521861/adolescent-nicotine-exposure-induces-long-term-sex-specific-disturbances-in-mood-and-anxiety-related-behavioral-neuronal-and-molecular-phenotypes-in-the-mesocorticolimbic-system
#13
JOURNAL ARTICLE
Tsun Hay Jason Ng, Mohammed H Sarikahya, Roger Hudson, Hanna J Szkudlarek, Enzo Pérez-Valenzuela, Taygun C Uzuneser, Emma Proud, Dana Gummerson, Miray Youssef, Madeline Machado, Kuralay Zhaksylyk, Marieka V DeVuono, Chaochao Chen, Ken K-C Yeung, Walter J Rushlow, Steven R Laviolette
The majority of lifetime smokers begin using nicotine during adolescence, a critical period of brain development wherein neural circuits critical for mood, affect and cognition are vulnerable to drug-related insults. Specifically, brain regions such as the medial prefrontal cortex (mPFC), the ventral tegmental area (VTA), nucleus accumbens (NAc) and hippocampus, are implicated in both nicotine dependence and pathological phenotypes linked to mood and anxiety disorders. Clinical studies report that females experience higher rates of mood/anxiety disorders and are more resistant to smoking cessation therapies, suggesting potential sex-specific responses to nicotine exposure and later-life neuropsychiatric risk...
March 23, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38521860/protective-effect-of-pde4b-subtype-specific-inhibition-in-an-app-knock-in-mouse-model-for-alzheimer-s-disease
#14
JOURNAL ARTICLE
Paul Armstrong, Hüseyin Güngör, Pariya Anongjanya, Clare Tweedy, Edward Parkin, Jamie Johnston, Ian M Carr, Neil Dawson, Steven J Clapcote
Meta-analysis of genome-wide association study data has implicated PDE4B in the pathogenesis of Alzheimer's disease (AD), the leading cause of senile dementia. PDE4B encodes one of four subtypes of cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase-4 (PDE4A-D). To interrogate the involvement of PDE4B in the manifestation of AD-related phenotypes, the effects of a hypomorphic mutation (Pde4bY358C ) that decreases PDE4B's cAMP hydrolytic activity were evaluated in the AppNL-G-F knock-in mouse model of AD using the Barnes maze test of spatial memory, 14 C-2-deoxyglucose autoradiography, thioflavin-S staining of β-amyloid (Aβ) plaques, and inflammatory marker assay and transcriptomic analysis (RNA sequencing) of cerebral cortical tissue...
March 23, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38504012/dorsal-ca3-overactivation-mediates-witnessing-stress-induced-recognition-memory-deficits-in-adolescent-male-mice
#15
JOURNAL ARTICLE
Xiao Liu, Rui Liu, Ya-Xin Sun, Hong-Li Wang, Han Wang, Ting Wang, Yu-Nu Ma, Xue-Xin Li, Qi Wang, Yun-Ai Su, Ji-Tao Li, Tian-Mei Si
Witnessing violent or traumatic events is common during childhood and adolescence and could cause detrimental effects such as increased risks of psychiatric disorders. This stressor could be modeled in adolescent laboratory animals using the chronic witnessing social defeat (CWSD) paradigm, but the behavioral consequences of CWSD in adolescent animals remain to be validated for cognitive, anxiety-like, and depression-like behaviors and, more importantly, the underlying neural mechanisms remain to be uncovered...
March 19, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38499720/dnmt3a1-regulates-hippocampus-dependent-memory-via-the-downstream-target-nrp1
#16
JOURNAL ARTICLE
Janina Kupke, Julien Klimmt, Franziska Mudlaff, Maximilian Schwab, Pavlo Lutsik, Christoph Plass, Carsten Sticht, Ana M M Oliveira
Epigenetic factors are well-established players in memory formation. Specifically, DNA methylation is necessary for the formation of long-term memory in multiple brain regions including the hippocampus. Despite the demonstrated role of DNA methyltransferases (Dnmts) in memory formation, it is unclear whether individual Dnmts have unique or redundant functions in long-term memory formation. Furthermore, the downstream processes controlled by Dnmts during memory consolidation have not been investigated. In this study, we demonstrated that Dnmt3a1, the predominant Dnmt in the adult brain, is required for long-term spatial object recognition and contextual fear memory...
March 18, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38499719/insular-cortex-subregions-have-distinct-roles-in-cued-heroin-seeking-after-extinction-learning-and-prolonged-withdrawal-in-rats
#17
JOURNAL ARTICLE
Matthew S McGregor, Caitlin V Cosme, Ryan T LaLumiere
Evidence indicates that the anterior (aIC), but not posterior (pIC), insular cortex promotes cued reinstatement of cocaine seeking after extinction in rats. It is unknown whether these subregions also regulate heroin seeking and whether such involvement depends on prior extinction learning. To address these questions, we used baclofen and muscimol (BM) to inactivate the aIC or pIC bilaterally during a seeking test after extinction or prolonged withdrawal from heroin. Male Sprague-Dawley rats in the extinction groups underwent 10+ days of heroin self-administration, followed by 6+ days of extinction sessions, and subsequent cued or heroin-primed reinstatement...
March 18, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38491123/does-steroid-increase-lps-induced-sickness-behaviors
#18
LETTER
Kubra Karadag, Bariscan Cimen, Mert Ertunc, Yildirim Sara
No abstract text is available yet for this article.
March 15, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38486051/in-memoriam-brian-e-leonard-phd-dsc-mria
#19
EDITORIAL
John F Cryan
No abstract text is available yet for this article.
March 14, 2024: Neuropsychopharmacology
https://read.qxmd.com/read/38480911/clinical-decision-support-for-bipolar-depression-using-large-language-models
#20
JOURNAL ARTICLE
Roy H Perlis, Joseph F Goldberg, Michael J Ostacher, Christopher D Schneck
Management of depressive episodes in bipolar disorder remains challenging for clinicians despite the availability of treatment guidelines. In other contexts, large language models have yielded promising results for supporting clinical decisionmaking. We developed 50 sets of clinical vignettes reflecting bipolar depression and presented them to experts in bipolar disorder, who were asked to identify 5 optimal next-step pharmacotherapies and 5 poor or contraindicated choices. The same vignettes were then presented to a large language model (GPT4-turbo; gpt-4-1106-preview), with or without augmentation by prompting with recent bipolar treatment guidelines, and asked to identify the optimal next-step pharmacotherapy...
March 13, 2024: Neuropsychopharmacology
journal
journal
30084
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.